Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Doctors Influenced By Kickbacks, Overprescribe Painkillers, Studies Show August 8, 2013 Irvin Jackson Add Your Comments Two new studies suggest that doctors overprescribe painkillers and that they may be swayed to prescribe any drug too often if presented with kickbacks, such as money and gifts, from drug companies and sales reps. In a study published last week by the Social Science Research Network, researchers from the Rady School of Management at University of California, San Diego found that more than half of the 330,000 physicians in their study received payment of some kind for prescribing specific drugs. “When a doctor is paid, we find he is more likely to prescribe a drug of the paying firm, both relative to close substitutes and even generic versions of the same drug,” they determined. “This payment-for-prescription effect scales with transfer size, although doctors receiving only small and/or infrequent payments are also affected. Although the pattern holds in nearly every U.S. state, it is strongly and positively related to regional measures of corruption.” Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The report came ahead of the Physician Payments Sunshine Act, which takes effect next year, requiring drug and medical device manufacturers to publicly report payments to physicians and teaching hospitals. In 2009, payments from pharmaceutical companies to doctors was at about $188.86 million. By 2011, that number had jumped to $773.05 million, but much of that increase was attributed to companies being more willing to admit how much they had paid out. Most payments came in the form of meals, ranging around $37 per meal. The average doctor in the study generated about 2,980 prescriptions from 217 patients. However, doctors who got payments from pharmaceutical companies gave out 3,566 prescriptions fomr 243 patients. These same doctors were more likely to prescribe a brand name drug than a generic version. Kickback Schemes Lead to Government Fraud Lawsuits In recent years, number of companies have been hit by lawsuits from the Department of Justice over such claims. One of the largest resulted in a Pfizer settlement for $2.3 billion in 2009, after the drug maker was accused of illegal marketing and kickbacks associated with the painkiller Bextra and other drugs. Prosecutors said Pfizer gave doctors kickbacks and incentives that included paying them for weekend meetings in resort locations. Just this year, C.R. Bard agreed to pay $48.26 million to settle a whistleblower lawsuit which claimed it paid illegal kickbacks to doctors who used its radioactive seeds to treat prostate cancer. The company gave them free medical supplies, grants, rebates, conferencing fees and marketing assistance. Such kickback schemes are considered a form of Medicare fraud. Doctors Overprescribing Painkillers In the second of the recent studies, Harvard researchers found one possible side effect of all those kickbacks. They determined that overall doctors are prescribing too many powerful painkillers and requesting too many expensive tests for back pain due to confusing treatment guidelines. The study was published late last month in the medical journal JAMA Internal Medicine, finding that doctors have reduced the number of prescriptions of acetaminophen and other nonsteroidal anti-inflammatory drugs (NSAIDs) for back pain and increased the number of narcotic prescriptions. They are also prescribing more computed tomograms and magnetic resonance images (MRIs), though researchers could find nothing to account for the changes. Researchers looked at nationally representative data from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey to assess back pain treatment from January 1, 1999, through December 26, 2010. They found that the rate of prescription of acetaminophen (the primary ingredient in Tylenol) and NSAIDs such as Motrin and Alleve for back pain had decreased from 36.9% in 1999-2000 to 24.5% in 2009-2010. At the same time, the rate of prescription of narcotics for back pain, like OxyContin and Vicodin, increased from 19.3% to 29.1%. The rate of expensive scans such as MRIs for back-related pain also increased from 7.2% to 11.3% over the course of the study. Researchers in the Harvard study blamed the changes on “discordant” guidelines for back pain management and treatment. “Improvements in the management of spine-related disease represent an area of potential cost savings for the health care system with the potential for improving the quality of care,” the researchers determined. Tags: Acetaminophen, Bextra, C. R. Bard, Epidural Steroid Injection, Fungal Meningitis, MRI, Oxycontin, Pfizer, Tylenol, Whistleblower More Lawsuit Stories Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 July 8, 2025 Mead Johnson Must Face Enfamil NEC Lawsuit in Missouri State Court July 8, 2025 FanDuel Class Action Lawsuit Alleges Fantasy Games Constitute Illegal Sports Gambling July 8, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)